CareDx Inc
NASDAQ:CDNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CareDx Inc
NASDAQ:CDNA
|
US |
|
C
|
CanadaBis Capital Inc
OTC:CNADF
|
CA |
|
K
|
Kinder Morgan Inc
XMUN:2KD
|
US |
|
Aerison Group Ltd
ASX:AE1
|
AU |
|
Comcast Corp
NASDAQ:CMCSV
|
US |
|
H
|
H & R Block Inc
XMUN:HRB
|
US |
|
Silver Hammer Mining Corp
OTC:HAMRF
|
CA |
|
D
|
Deluxe Corp
XMUN:DL8
|
US |
|
C
|
Credit Suisse Group AG
XBER:CSX
|
CH |
|
MMTEC Inc
NASDAQ:MTC
|
CN |
|
U
|
US BioTec Inc
OTC:USBC
|
US |
|
C
|
CITIC Pacific Special Steel Group Co Ltd
SZSE:000708
|
CN |
|
Anteotech Ltd
ASX:ADO
|
AU |
|
C
|
Comcast Corp
DUS:CTP2
|
US |
|
Cloudcall Group PLC
LSE:CALL
|
UK |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
Wall St Price Targets
CDNA Price Targets Summary
CareDx Inc
According to Wall Street analysts, the average 1-year price target for
CDNA is 53.38 USD with a low forecast of 40.4 USD and a high forecast of 67.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CDNA's stock price target?
Price Target
53.38
USD
According to Wall Street analysts, the average 1-year price target for
CDNA is 53.38 USD with a low forecast of 40.4 USD and a high forecast of 67.2 USD.
What is the Revenue forecast for CareDx Inc?
Projected CAGR
14%
Over the last 12 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 3 years is 14%.
What is the Gross Profit forecast for CareDx Inc?
Projected CAGR
14%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 28%. The projected CAGR for the next 3 years is 14%.